A carregar...
Challenge of immune-mediated adverse reactions in the emergency department
Multiple drugs of a new class of cancer treatments called immune checkpoint inhibitors, which work by enabling the immune system to attack tumour cells, have been approved for a variety of indications in recent years. Immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 and programmed death-...
Na minha lista:
| Publicado no: | Emerg Med J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582806/ https://ncbi.nlm.nih.gov/pubmed/31113799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/emermed-2018-208206 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|